SPINAL MUSCULAR ATROPHY STUDIES
Transgenic SMA models available immediately to advance your pipeline.
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR SPINAL MUSCULAR ATROPHY PROGRAM.

MODELS / SERVICES
Why choose PharmaLegacy?
- Ability to start most studies in under 2 weeks
- Our scientific staff average 15+ years of experience
- 1500+ validated animal models of disease spanning 100+ indications
- Competitive pricing without compromise to data quality
We’ve led over 600 pipelines to NDA. We can do the same for you. Contact us today.
We’re ready when you are.
Tell us your Spinal Muscular Atrophy pipeline challenges.